Characterization of proteoglycan production and processing by chondrocytes and BMSCs in tissue engineered constructs - Wikidata - wikimedia - TriplyDB

Characterization of proteoglycan production and processing by chondrocytes and BMSCs in tissue engineered constructs

Characterization of proteoglycan production and processing by chondrocytes and BMSCs in tissue engineered constructs

http://www.wikidata.org/entity/Q37020871

about

Mesenchymal stem cells for cartilage repair in osteoarthritis Identification and clonal characterisation of a progenitor cell sub-population in normal human articular cartilage Self-assembling peptide hydrogels modulate in vitro chondrogenesis of bovine bone marrow stromal cells.Adult equine bone marrow stromal cells produce a cartilage-like ECM mechanically superior to animal-matched adult chondrocytes.Tensile loading modulates bone marrow stromal cell differentiation and the development of engineered fibrocartilage constructs.Adult bone marrow stromal cell-based tissue-engineered aggrecan exhibits ultrastructure and nanomechanical properties superior to native cartilage Controlled delivery of transforming growth factor β1 by self-assembling peptide hydrogels induces chondrogenesis of bone marrow stromal cells and modulates Smad2/3 signaling.Gel structure has an impact on pericellular and extracellular matrix deposition, which subsequently alters metabolic activities in chondrocyte-laden PEG hydrogels.Growth factor priming of synovium-derived stem cells for cartilage tissue engineering.Posttraumatic knee osteoarthritis following anterior cruciate ligament injury: Potential biochemical mediators of degenerative alteration and specific biochemical markers.An enzyme-sensitive PEG hydrogel based on aggrecan catabolism for cartilage tissue engineering A micro-architecturally biomimetic collagen template for mesenchymal condensation based cartilage regeneration.Toward engineering a biological joint replacement.Fibronectin- and collagen-mimetic ligands regulate bone marrow stromal cell chondrogenesis in three-dimensional hydrogels Role of Chondrocytes in Cartilage Formation, Progression of Osteoarthritis and Cartilage Regeneration.Synthesis of and in vitro and in vivo evaluation of a novel TGF-β1-SF-CS three-dimensional scaffold for bone tissue engineering.Mesenchymal Stem Cells for Treating Articular Cartilage Defects and Osteoarthritis.Application of Extrusion-Based Hydrogel Bioprinting for Cartilage Tissue Engineering Use of a centrifugal bioreactor for cartilaginous tissue formation from isolated chondrocytes.Variations in chondrogenesis of human bone marrow-derived mesenchymal stem cells in fibrin/alginate blended hydrogels.In vitro culture of hFOB1.19 osteoblast cells on TGF-β1-SF-CS three-dimensional scaffolds.Characterization of a cartilage-like engineered biomass using a self-aggregating suspension culture model: molecular composition using FT-IRIS.RGD-functionalized polyethylene glycol hydrogels support proliferation and in vitro chondrogenesis of human periosteum-derived cells.Next Generation Tissue Engineering of Orthopedic Soft Tissue-to-Bone Interfaces.Chondrocytes and bone marrow-derived mesenchymal stem cells undergoing chondrogenesis in agarose hydrogels of solid and channelled architectures respond differentially to dynamic culture conditions.Effect of double growth factor release on cartilage tissue engineering.

P2860

Q26991970-5F8C43AE-17F5-497B-A72D-2893511A168B Q33728590-FBBCB057-E307-43BD-B3ED-3E5DE9ACE2BC Q33822587-07172972-FC15-4F2C-BDE2-7BECF111043E Q33952550-AD3B0E86-69AD-49E5-B90C-0D3890E6229A Q34171254-1FC318E8-3CCB-447F-914D-86484557968D Q34289098-93FF383B-FC95-4248-BE17-6F8D1AD2CCBD Q34447278-0D4FAAEA-7C6F-4964-A16B-3C988C13DA78 Q34459052-CBB92E92-8219-4972-B04C-BD76FDBAEAAA Q35179352-0996D9A2-D843-40AD-9D1C-5E4FD845DED6 Q35180074-FC7E988D-5CA3-4D7F-8813-917684F26E63 Q35892673-2928A4AE-59D8-40E6-91B1-3E7D491B693A Q36414566-C6328A23-6782-43C1-B59C-08DAE2DF1D03 Q36980666-0753DE97-088E-48F1-BCD1-205F16351533 Q37020597-C40AA545-F03F-403A-9422-111D9EEFABF1 Q37027619-7977BDDD-A12A-4D34-BCED-D130092EE2BB Q37071721-0975AD41-A523-412E-8304-AD828DA51185 Q38246799-BD3526F5-13E6-44EA-A750-97E94FD2593D Q38652777-0987E088-237E-4C50-B2F0-F0D1D3BB65B8 Q39549728-CB31053F-11AF-4E66-880A-4CA053E10A02 Q39593401-52909804-4136-4E36-8C33-4D7B0EC3E5FA Q42065278-512B633E-EC71-4CEE-9D08-8CEB09159E75 Q42597056-F6D99E25-456C-47F9-90B3-555812513B74 Q47712020-FBEDAD1D-03E8-4013-804F-A17CBFEEE824 Q50049707-8F0DCC78-3FB2-4B98-8CD0-76AA74D36ECF Q50270754-4B46B5F4-0DD9-4578-BDCD-2D01F3816E9D Q54339408-AD2999B1-9C3D-47BA-83B2-3A35F71C7D44

P2860

Characterization of proteoglycan production and processing by chondrocytes and BMSCs in tissue engineered constructs

http://www.wikidata.org/entity/Q37020871

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 February 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Characterization of proteoglyc ...... n tissue engineered constructs

@en

Characterization of proteoglyc ...... tissue engineered constructs.

@nl

type

label

Characterization of proteoglyc ...... n tissue engineered constructs

@en

Characterization of proteoglyc ...... tissue engineered constructs.

@nl

prefLabel

Characterization of proteoglyc ...... n tissue engineered constructs

@en

Characterization of proteoglyc ...... tissue engineered constructs.

@nl

P1433

Q37020871-DCD75748-3A14-4586-AC7D-772E6E4F2B8E

P1476

Q37020871-433DACE3-CD84-462D-83CB-C1A1D10C3181

P2093

Q37020871-0614FF06-76C4-4D81-8362-3DBC1C8662D9

Q37020871-80E2D6DA-2055-4205-B232-FAEBFA3BD359

Q37020871-99413FD8-E84E-4267-87D8-F54059218AD6

P2860

Q37020871-0A7D17DD-6C7E-4E00-B72C-966C35175999

Q37020871-0DE04B98-3F52-470D-86F7-E09676A2EEB2

Q37020871-116E7382-BEFF-441B-9D49-3D098D09D63B

Q37020871-11763597-755D-4105-8221-84672DF04928

Q37020871-121F1AA8-E7B0-4515-94B4-F280E2274303

Q37020871-13F34706-005E-4E36-A18C-E4E8CFD263C0

Q37020871-14FBEEFE-1158-45A1-B095-E19885DEF6F9

Q37020871-1A799087-D736-45B5-B8AC-DFF4C43D595D

Q37020871-1C162E21-FE03-40B4-99A9-58E314C24045

Q37020871-26577A4E-7F3C-4CDF-85D6-9E8746556713

P304

Q37020871-9E6FD935-A3BF-46D5-8DCE-8450AB09365E

P31

Q37020871-C931D051-427E-42FA-B6A4-05C24E0C9A1C

P356

Q37020871-F2ED5CC0-68BE-48CB-92C3-038DF30E00A3

P433

Q37020871-07376550-1908-4361-BFA9-A189C1CC66A2

P478

Q37020871-CFA20971-A7CE-46BC-B6B7-A39A907529B7

P577

Q37020871-21946DB7-6392-4F8F-A16B-69066D795915

P5875

Q37020871-54EEE64C-B529-440A-BEF4-A1724E8CD569

P698

Q37020871-F2C2C8E8-BF85-4CB5-9B32-BBC909173AF5

P932

Q37020871-7E2A8F97-F9EC-4B21-8483-55E40C2D2277

P356

J.JOCA.2008.01.004

P1433

Osteoarthritis and Cartilage

P1476

Characterization of proteoglyc ...... n tissue engineered constructs

@en

P2093

C G Wilson

http://www.w3.org/2001/XMLSchema#string

J T Connelly

http://www.w3.org/2001/XMLSchema#string

M E Levenston

http://www.w3.org/2001/XMLSchema#string

P2860

Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta

Multilineage potential of adult human mesenchymal stem cells

Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species

In situ hybridization and immunohistochemistry of versican, aggrecan and link protein, and histochemistry of hyaluronan in the developing mouse limb bud cartilage

Matrix metalloproteinases are involved in C-terminal and interglobular domain processing of cartilage aggrecan in late stage cartilage degradation.

The surface of articular cartilage contains a progenitor cell population.

Balance between swelling pressure and collagen tension in normal and degenerate cartilage.

Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5.

Chondrocyte-mediated catabolism of aggrecan: aggrecanase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine.

Selective and non-selective metalloproteinase inhibitors reduce IL-1-induced cartilage degradation and loss of mechanical properties.

P304

1092-1100

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JOCA.2008.01.004

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2008-02-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5557103

http://www.w3.org/2001/XMLSchema#string

P698

18294870

http://www.w3.org/2001/XMLSchema#string

P932

2605680

http://www.w3.org/2001/XMLSchema#string